A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and IRCCS Ospedale Policlinico San Martino has demonstrated the effectiveness of ...

Maxim Group analyst Michael Okunewitch has maintained their bullish stance on OCGN stock, giving a Buy rating on January 13.Invest with ...

It has been further shown that blind subjects suffering from retinitis pigmentosa do have phosphene perception when electrical current was applied to the retinal surface. Research groups and ...

Retinitis Pigmentosa is a genetic disorder that gradually ... Dexamethasone implant is also used to reduce macular edema. In more advanced cases, vitrectomy may be required. This surgical ...

The company is also tossing another rare disease clinical program, this one in X-linked retinitis pigmentosa ... late-stage testing for diabetic macular edema. In a phase 2 trial, the drug ...

Macular edema is the leading cause of visual loss in uveitic patients, and is a predictable feature of pars planitis, Behcet's and sarcoid uveitis, HLA-B27 related uveitis, and birdshot ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach. Two new ...